BioLargo Inc
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediati… Read more
BioLargo Inc (BLGO) - Total Liabilities
Latest total liabilities as of September 2025: $5.92 Million USD
Based on the latest financial reports, BioLargo Inc (BLGO) has total liabilities worth $5.92 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BioLargo Inc - Total Liabilities Trend (2000–2024)
This chart illustrates how BioLargo Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BioLargo Inc Competitors by Total Liabilities
The table below lists competitors of BioLargo Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gold Rain Enterprises
TWO:4503
|
Taiwan | NT$164.53 Million |
|
Excel Industries Limited
NSE:EXCELINDUS
|
India | ₹4.45 Billion |
|
FDC International Hotels Corp
TW:2748
|
Taiwan | NT$1.84 Billion |
|
Shotspotter Inc
NASDAQ:SSTI
|
USA | $63.58 Million |
|
Kalray SA
PA:ALKAL
|
France | €33.60 Million |
|
AML3D Ltd
AU:AL3
|
Australia | AU$6.69 Million |
|
GRIDWIZ
KQ:453450
|
Korea | ₩32.15 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down BioLargo Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioLargo Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioLargo Inc (2000–2024)
The table below shows the annual total liabilities of BioLargo Inc from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.46 Million | +11.34% |
| 2023-12-31 | $4.00 Million | +40.60% |
| 2022-12-31 | $2.85 Million | +36.22% |
| 2021-12-31 | $2.09 Million | -59.63% |
| 2020-12-31 | $5.18 Million | -10.76% |
| 2019-12-31 | $5.80 Million | +34.66% |
| 2018-12-31 | $4.31 Million | -12.17% |
| 2017-12-31 | $4.91 Million | +70.14% |
| 2016-12-31 | $2.88 Million | +274.92% |
| 2015-12-31 | $768.94K | +17.75% |
| 2014-12-31 | $653.00K | -10.79% |
| 2013-12-31 | $732.00K | +31.18% |
| 2012-12-31 | $558.00K | -68.37% |
| 2011-12-31 | $1.76 Million | -42.22% |
| 2010-12-31 | $3.05 Million | -24.51% |
| 2009-12-31 | $4.04 Million | +52.32% |
| 2008-12-31 | $2.65 Million | +9.62% |
| 2007-12-31 | $2.42 Million | -56.56% |
| 2006-12-31 | $5.58 Million | +9.87% |
| 2005-12-31 | $5.07 Million | +36.84% |
| 2004-12-31 | $3.71 Million | +26.77% |
| 2003-12-31 | $2.92 Million | +21.82% |
| 2002-12-31 | $2.40 Million | -29.07% |
| 2001-12-31 | $3.38 Million | -6.65% |
| 2000-12-31 | $3.63 Million | -- |